chr18-21573343-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_052911.3(ESCO1):āc.1501A>Gā(p.Lys501Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000158 in 1,581,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_052911.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ESCO1 | NM_052911.3 | c.1501A>G | p.Lys501Glu | missense_variant | 4/12 | ENST00000269214.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ESCO1 | ENST00000269214.10 | c.1501A>G | p.Lys501Glu | missense_variant | 4/12 | 1 | NM_052911.3 | P1 | |
ESCO1 | ENST00000383276.1 | c.1501A>G | p.Lys501Glu | missense_variant, NMD_transcript_variant | 4/13 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152256Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000272 AC: 6AN: 220438Hom.: 0 AF XY: 0.0000168 AC XY: 2AN XY: 119376
GnomAD4 exome AF: 0.00000630 AC: 9AN: 1429148Hom.: 0 Cov.: 30 AF XY: 0.00000563 AC XY: 4AN XY: 710274
GnomAD4 genome AF: 0.000105 AC: 16AN: 152256Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2022 | The c.1501A>G (p.K501E) alteration is located in exon 4 (coding exon 1) of the ESCO1 gene. This alteration results from a A to G substitution at nucleotide position 1501, causing the lysine (K) at amino acid position 501 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at